308.83
Evercore Inc stock is traded at $308.83, with a volume of 141.17K.
It is up +0.90% in the last 24 hours and down -4.72% over the past month.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
See More
Previous Close:
$306.20
Open:
$306.74
24h Volume:
141.17K
Relative Volume:
0.34
Market Cap:
$11.95B
Revenue:
$3.26B
Net Income/Loss:
$503.61M
P/E Ratio:
28.09
EPS:
10.9949
Net Cash Flow:
$718.54M
1W Performance:
+4.20%
1M Performance:
-4.72%
6M Performance:
+36.64%
1Y Performance:
-0.77%
Evercore Inc Stock (EVR) Company Profile
Name
Evercore Inc
Sector
Industry
Phone
212-857-3100
Address
55 EAST 52ND STREET, NEW YORK, NY
Compare EVR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EVR
Evercore Inc
|
308.92 | 11.84B | 3.26B | 503.61M | 718.54M | 10.99 |
|
MS
Morgan Stanley
|
163.64 | 251.38B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
791.24 | 232.15B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
90.56 | 160.83B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
114.53 | 96.48B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
348.38 | 27.53B | 14.13B | 1.12B | 45.45M | 14.62 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-09-25 | Initiated | Deutsche Bank | Buy |
| Oct-03-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jun-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-08-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Apr-07-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-20-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Sep-11-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-29-24 | Resumed | Keefe Bruyette | Mkt Perform |
| Jan-09-24 | Downgrade | UBS | Buy → Neutral |
| Aug-22-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-12-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-12-23 | Upgrade | UBS | Sell → Buy |
| Jan-11-23 | Upgrade | Goldman | Neutral → Buy |
| Oct-27-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-23-22 | Downgrade | UBS | Neutral → Sell |
| Jan-06-22 | Downgrade | Goldman | Buy → Neutral |
| Dec-08-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-09-21 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Mar-19-21 | Reiterated | Goldman | Buy |
| Jan-05-21 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-16-20 | Initiated | Seaport Global Securities | Buy |
| Dec-01-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-02-20 | Upgrade | UBS | Neutral → Buy |
| Aug-05-20 | Upgrade | Goldman | Neutral → Buy |
| Jul-09-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-25-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-06-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Nov-20-19 | Initiated | Morgan Stanley | Overweight |
| Aug-14-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-06-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-23-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jan-07-19 | Downgrade | Goldman | Neutral → Sell |
| Nov-06-18 | Initiated | Goldman | Neutral |
| Jan-09-18 | Upgrade | UBS | Neutral → Buy |
| May-23-17 | Downgrade | Goldman | Buy → Neutral |
| Mar-27-17 | Initiated | Keefe Bruyette | Mkt Perform |
| Feb-16-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-13-17 | Downgrade | Instinet | Buy → Neutral |
| Dec-14-16 | Initiated | BofA/Merrill | Neutral |
| Nov-21-16 | Resumed | Credit Suisse | Outperform |
View All
Evercore Inc Stock (EVR) Latest News
AutoNation (AN) Analyst Rating: Evercore ISI Group Raises Price Target to $300 | AN Stock News - GuruFocus
APTV: Evercore ISI Group Raises Price Target to $100 | APTV Stoc - GuruFocus
GM Stock: Evercore ISI Group Raises Price Target to $74.00 | GM - GuruFocus
Ford Motor (F): Evercore ISI Group Raises Price Target to $12.00 | F Stock News - GuruFocus
Lear (LEA): Evercore ISI Group Raises Price Target to $120.00 | LEA Stock News - GuruFocus
Evercore ISI Group Raises BorgWarner (BWA) Price Target, Maintai - GuruFocus
BJ's Wholesale Club (BJ) Analyst Rating Updated by Evercore | BJ Stock News - GuruFocus
Evercore ISI Group Maintains Magna International (MGA) Rating, R - GuruFocus
Evercore ISI Raises Price Target for Autoliv (ALV) to $150 | ALV Stock News - GuruFocus
Ford Motor (NYSE:F) Price Target Raised to $12.00 at Evercore ISI - MarketBeat
Beam Therapeutics (BEAM) Receives New 'Outperform' Rating from E - GuruFocus
Evercore ISI Remains Bullish on Air Products and Chemicals (APD) Following Q4 2025 Results - Insider Monkey
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - Yahoo Finance
QuantumScape (QS) Receives Downgrade from Evercore ISI Group Tod - GuruFocus
Evercore ISI Adjusts Price Target on Aptiv to $100 From $95, Maintains Outperform Rating - MarketScreener
Evercore ISI Adjusts Price Target on Align Technology to $220 From $170, Maintains Outperform Rating - MarketScreener
Viatris (Nasdaq: VTRS) schedules Dec. 2–3 fireside chats at Piper Sandler and Evercore - Stock Titan
Evercore ISI Downgrades QuantumScape to In Line From Outperform, Adjusts Price Target to $12 From $8 - MarketScreener
Vera Therapeutics (Nasdaq: VERA) joins Evercore and Citi 2025 healthcare investor events - Stock Titan
Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Skye Bioscience (NASDAQ: SKYE) to join Citi, Evercore and Piper Sandler healthcare investment conferences - Stock Titan
Evercore ISI raises BJ’s Wholesale stock price target to $95 on member focus - Investing.com India
Evercore ISI lowers Post Holdings stock price target on cereal concerns - Investing.com India
Zymeworks (NASDAQ: ZYME) to Join Evercore, Citi 2025 Healthcare Conferences - Stock Titan
Why You Might Be Interested In Evercore Inc. (NYSE:EVR) For Its Upcoming Dividend - Yahoo Finance
NVDA: Nvidia Hits New Street-High Target -- Stock Could Jump 95% - Yahoo Finance
Gap price target raised to $28 from $25 at Evercore ISI - Yahoo Finance
Nvidia to skyrocket 95%? Evercore drops a target that has Wall Street buzzinghere's the reason it gave - The Economic Times
Ryman (RHP) Receives a Buy from Evercore ISI - The Globe and Mail
Pebblebrook Hotel (PEB) Gets a Hold from Evercore ISI - The Globe and Mail
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December - Koreabizwire
Lazard, Evercore, and BGC Shares Are Soaring, What You Need To Know - Finviz
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Teva Pharmaceutical (NYSE: TEVA) to present at three December 2025 investor conferences - Stock Titan
Wix.com (NASDAQ:WIX) Price Target Cut to $160.00 by Analysts at Evercore ISI - MarketBeat
Evercore ISI Forecasts Strong Price Appreciation for Lowe's Companies (NYSE:LOW) Stock - MarketBeat
Nvidia Stock Could Jump 95% After Evercore Sets New Street-High Target - TradingView
Ross Stores (ROST) Analyst Rating Update: Evercore ISI Group Rai - GuruFocus
Evercore ISI Adjusts Price Target on Walmart to $115 From $111, Maintains Outperform Rating - MarketScreener
Why institutional investors increase stakes in Evercore Inc. (QGJ) stock - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated at Evercore ISI - MarketBeat
Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference - Yahoo Finance Singapore
Adlai Nortye (NASDAQ: ANL) to present at Evercore and Oppenheimer healthcare conferences - Stock Titan
How Evercore Inc. stock reacts to Fed rate cutsJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - newser.com
Ross Stores stock price target raised to $195 by Evercore ISI after strong Q3 - Investing.com India
Intuit stock rating reiterated at Outperform by Evercore ISI - Investing.com India
Gap stock price target raised to $28 from $25 at Evercore ISI - Investing.com India
Evercore ISI raises Walmart stock price target to $115 on digital growth - Investing.com Canada
Evercore ISI Adjusts Price Target on Ross Stores to $195 From $175, Maintains Outperform Rating - MarketScreener
Is Evercore Inc. Class stock supported by strong fundamentals2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Evercore Inc Stock (EVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):